🇺🇸 FDA
Pipeline program

GX-03

Protocol/Panel 4604

Phase 2 other active

Quick answer

GX-03 for Eczema Atopic Dermatitis is a Phase 2 program (other) at Turn Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Turn Therapeutics
Indication
Eczema Atopic Dermatitis
Phase
Phase 2
Modality
other
Status
active

Clinical trials